Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-27.67x5.75x2.24x3.85x-34x-26.55x-.--% 4.3B
45.97x7.26x2.06x10.92x39.12x40.38x0.02% 49.27B
18.09x4.33x0.24x6.45x14.35x15.8x1.6% 44.15B
-27.24x93x-3.52x62.44x-30.44x-29.42x-.--% 34.86B
-27.63x1.26x-1.24x4.79x-13.08x-10.34x-.--% 27.38B
33.11x3.07x0.86x6.55x18.16x22.61x-.--% 21.21B
19.16x3.63x-5.98x4.92x12.9x13.86x-.--% 21.63B
-202.83x24.86x-2.58x48.32x-195.77x-173.36x-.--% 13.95B
-459.52x13.39x7.66x29.32x608.28x-489.85x-.--% 14.58B
-13.59x - -0.05x170.31x-26.56x-13.29x-.--% 13.61B
17.35x4.66x0.36x4.98x12.33x13.6x-.--% 12.18B
-48x19.01x0.92x11.52x-44.97x-43.21x-.--% 11.47B
-18.71x16.56x-0x20.8x-26.35x-18.91x-.--% 9.06B
-163.4x20.27x2.01x18.85x330.82x-130.32x-.--% 7.66B
-18.85x8.12x-0.41x - -19.41x-18.75x-.--% 8.37B
-10.16x-14.07x-0.49x92.3x-12.43x-12.18x-.--% 7.9B
813.26x42.88x-6.75x98.06x882.1x1141.06x - 7.23B
Average -4.16x 15.87x -0.27x 37.15x 89.12x 16.54x 0.1% 18.17B
Weighted average by Cap. -11.25x 18.24x -0.31x 29.21x 50.14x -3.87x 0.24%
Bio Therapeutic Drugs